These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 7060063)

  • 1. [Secondary prevention in coronary syndrome patients up to the age of 55 (author's transl)].
    Rysavý F; Plísek V; Zák J; Lupínek Z; Argalás K; Lupínková Z
    Cas Lek Cesk; 1982 Jan; 121(2):52-7. PubMed ID: 7060063
    [No Abstract]   [Full Text] [Related]  

  • 2. [Krakow Program for Secondary Prevention of Ischaemic Heart Disease. Part II. Secondary prevention of ischaemic heart disease during hospitalization].
    Kawecka-Jaszcz K; Jankowski P; Pajak A; Dubiel J; Maciejewicz J; Piotrowski W; Smielak-Korombel W; Tracz W
    Przegl Lek; 2001; 58(11):956-63. PubMed ID: 11987835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Analysis of factors associated with cardiovascular mortality in patients listed in the group of secondary prevention of myocardial infarction (author's transl)].
    Válek J; Hammer J; Vondra K; Grafnetter D; Slabochová Z; Kohout M; Stolz I
    Cas Lek Cesk; 1981 Apr; 120(13):380-4. PubMed ID: 7214418
    [No Abstract]   [Full Text] [Related]  

  • 4. [Justification for anticoagulative treatment after myocardial infarction (author's transl)].
    Barrillon A; Gerbaux A
    Ann Cardiol Angeiol (Paris); 1976; 25(1):23-30. PubMed ID: 1259339
    [No Abstract]   [Full Text] [Related]  

  • 5. [Sports, physical activity and risk for coronary heart disease (author's transl)].
    Pfisterer M
    Z Kardiol; 1981 Feb; 70(2):104-10. PubMed ID: 7222903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Percutaneous coronary interventions in elderly patients: clinical indications and adjunctive medical treatment. The Italian Drug Evaluation in Angioplasty (IDEA) study].
    Bossi I; Piccaluga E; Scatturin M; Corvaja N; Pasquetto G; Steffanon L; Oberhollenzer R; Colombo P; Bolognese L; Savonitto S
    G Ital Cardiol (Rome); 2006 Feb; 7(2):136-44. PubMed ID: 16532725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The programme and aims of secondary prevention of myocardial infarction. Present experiences in Prague 4 (author's transl)].
    Hammer J; Válek J; Grafnetter D; Slabochová Z; Pavlovic J; Stolz I; Málková J
    Cas Lek Cesk; 1977 Jun; 116(23):715-8. PubMed ID: 890716
    [No Abstract]   [Full Text] [Related]  

  • 8. [Secondary prevention in patients after myocardial infarction by means of Tromcardin forte (author's transl)].
    Geizerová H; Widimský J
    Cas Lek Cesk; 1974 May; 113(21-22):672-7. PubMed ID: 4615795
    [No Abstract]   [Full Text] [Related]  

  • 9. [Cardiovascular disease control in the Czechoslovak population (author's transl)].
    Hurych J; Písa Z
    Cas Lek Cesk; 1980 Dec; 119(50):1373-6. PubMed ID: 7459965
    [No Abstract]   [Full Text] [Related]  

  • 10. Impact of briefly-assessed depression on secondary prevention outcomes after acute coronary syndrome: a one-year longitudinal survey.
    McGee HM; Doyle F; Conroy RM; De La Harpe D; Shelley E
    BMC Health Serv Res; 2006 Feb; 6():9. PubMed ID: 16476160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relation of clinical benefit of raising high-density lipoprotein cholesterol to serum levels of low-density lipoprotein cholesterol in patients with coronary heart disease (from the Bezafibrate Infarction Prevention Trial).
    Goldenberg I; Benderly M; Sidi R; Boyko V; Tenenbaum A; Tanne D; Behar S
    Am J Cardiol; 2009 Jan; 103(1):41-5. PubMed ID: 19101227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decline of coronary heart disease mortality in The Netherlands from 1978 to 1985: contribution of medical care and changes over time in presence of major cardiovascular risk factors.
    Bots ML; Grobbee DE
    J Cardiovasc Risk; 1996 Jun; 3(3):271-6. PubMed ID: 8863098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased risk of acute myocardial infarction for patients with panic disorder: a nationwide population-based study.
    Chen YH; Tsai SY; Lee HC; Lin HC
    Psychosom Med; 2009 Sep; 71(7):798-804. PubMed ID: 19592516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Bucharest multifactorial prevention trial. The changes of morbidity and of general and specific mortality.
    Steinbach M; Constantineanu M; Harnagea P; Theodorini S; Georgescu M; Mitu S; Tănăseanu S; Tănăsescu C; Teodorescu S; Voiculescu M; Voiosu R; Schioiu L; Galfi L; Damşa T; Bergthaller C
    Med Interne; 1982; 20(3):197-208. PubMed ID: 7156815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of high-dose statin administered prior to coronary angioplasty on the incidence of cardiac events in patients with acute coronary syndrome.
    Chyrchel M; Rakowski T; Rzeszutko L; Legutko J; Dziewierz A; Dubiel JS; Dudek D
    Kardiol Pol; 2006 Dec; 64(12):1357-62; discussion 1363. PubMed ID: 17206539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Sudden death in ischaemic heart disease--scope for prevention (author's transl)].
    Fejfar Z; Vrána M
    Cas Lek Cesk; 1980 Dec; 119(50):1368-72. PubMed ID: 7459964
    [No Abstract]   [Full Text] [Related]  

  • 17. Current standard of care in patients affected by coronary heart disease in Italy: the MC'95 study.
    Magnani B; Dal Palù C; Zanchetti A;
    Ital Heart J; 2002 Feb; 3(2):86-95. PubMed ID: 11926017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simvastatin for secondary prevention of all-cause mortality and major coronary events in patients with mild chronic renal insufficiency.
    Chonchol M; Cook T; Kjekshus J; Pedersen TR; Lindenfeld J
    Am J Kidney Dis; 2007 Mar; 49(3):373-82. PubMed ID: 17336698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cracovian Program for Secondary Prevention of Ischaemic Heart Disease. The quality of care in the field of secondary prevention of ischaemic heart disease depends on where patients are treated in the postdischarge period].
    Jankowski P; Kawecka-Jaszcz K; Pajak A
    Przegl Lek; 2001; 58 Suppl 6():21-5. PubMed ID: 11873737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of B-type natriuretic peptide in addition to troponin I, creatine kinase-MB, and myoglobin on the risk stratification of emergency department chest pain patients with potential acute coronary syndrome.
    Brown AM; Sease KL; Robey JL; Shofer FS; Hollander JE
    Ann Emerg Med; 2007 Feb; 49(2):153-63. PubMed ID: 17084941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.